Table of Contents

Part 1: Introduction.

1 Conceptual Antecedents of the Anxiety Disorders.

Part 2: Symptoms and Syndromes.

2 Relationships Among Anxiety Disorders: Patterns and Implications.

3 Panic Disorder: Symptoms and Syndromes.

4 Genralized Anxiety Disorder.

5 Post-traumatic Stress Disorder.

6 Obsessive-compulsive Disorder.

7 Social Anxiety Disorder.

8 Sleep Aspects inAnxiety Disorder.

9 Childhood Antecedents of Adult Anxiety Disorders.

10 Anxiety and Schizophrenia.

Part 3: Mechanisms.

11 Neurochemical Aspects of Anxiety.

12 Brain Imaging and Anxiety Disorders.

13 Genetics Dissection of Anxiety and Related Disorders.

14 Respiration and Anxiety.

15 Pharmacological Challenge Agents in Anxiety.

16 Panic Disorders and Medical Illness.

Part 4: Treatments.

17 Benzodiazepines.

18 Selective Serotonin Reuptake Inhibitors innthe Treatment of the Anxiety Disorders.

19 Treatment of the Anxiety Disorders with Tricyclic Antidepressants.

20 Buspirone in the Treatment of Anxiety Disorders.

21 Antihistamines in the Treatment of Psychic and Somatic Anxiety States.

22 Anxiety Disorders: New Antidepressants.

23 Cognitive Behavioral Treatment of Anxiety Disorders.

24 Exposure Therapy and Treatment of Anxiety Disorders.

25 Anxiety Disorders: Alternative Drug Treatments.

26 Physical Treatments.

27 Herbal Therapy and Anxiety.

Part 5: Conclusion.

28 Anxiety Disorders: Current Needs and Future Prospects.

Index

About the Author

David John Nutt is a British neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He was until 2009 a professor at the University of Bristol heading their Psychopharmacology Unit.

James C. Ballenger is the editor of Anxiety Disorders, published by Wiley.